Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Infect Disord Drug Targets ; 17(2): 116-119, 2017.
Article in English | MEDLINE | ID: mdl-28164754

ABSTRACT

OBJECTIVE: The present study assessed the prevalence of adverse drug reactions (ADRs) among HIV positive patients taking antiretroviral therapy referred to Imam Khomeini Hospital in Tehran, Iran. METHODS: This is a cross sectional study regarding side effects of Highly Active Antiretroviral Therapy (HAART) in HIV positive patients referred to Voluntary Counseling and Testing (VCT) center in Imam Khomeini Hospital of Tehran, Iran during a period of the year 2009 to 2010. Two hundred patients under antiretroviral treatment evaluated for the side effects of drug based on available records, face to face interviews and written lab data. RESULTS: Data was collected from a sample of 200 HIV positive patients (72% male). Injection drug use was the most common route of HIV transmission. Co-Infections with Hepatitis C virus (HCV) found in the majority of patients (60.5%). Tuberculosis was the most prevalent opportunistic infection. One hundred eighty eight (94%) patients experienced at least one adverse drug reaction. The most frequent clinical and paraclinical findings were skin rash (28%) and abnormal liver function tests (36%). CONCLUSION: Given the high prevalence of adverse drug reactions among HIV positive patients taking antiretroviral therapy (ART) in this study, clinicians should be aware of ADRs at the initiation of ART as complications can affect patients' adherence to the therapy.


Subject(s)
Anti-HIV Agents/adverse effects , Antiretroviral Therapy, Highly Active/adverse effects , HIV Infections/drug therapy , AIDS-Related Opportunistic Infections/drug therapy , Adolescent , Adult , Aged , Anti-HIV Agents/therapeutic use , CD4 Lymphocyte Count , Child , Child, Preschool , Coinfection/drug therapy , Coinfection/epidemiology , Coinfection/microbiology , Coinfection/virology , Cross-Sectional Studies , Female , HIV Infections/complications , HIV Infections/transmission , HIV Infections/virology , Hepatitis C/complications , Humans , Iran/epidemiology , Male , Middle Aged , Prevalence , Treatment Adherence and Compliance , Tuberculosis/complications , Young Adult
2.
Am J Pharm Educ ; 74(2): 25, 2010 Mar 10.
Article in English | MEDLINE | ID: mdl-20414438

ABSTRACT

The Accreditation Council for Pharmacy Education (ACPE) Accreditation Standards and Guidelines 2007 states that colleges and schools of pharmacy must have a remediation policy. Few comparative studies on remediation have been published by colleges and schools of pharmacy, making it challenging to implement effective and validated approaches. Effective remediation policies should include early detection of problems in academic performance, strategies to help students develop better approaches for academic success, and facilitation of self-directed learning. While the cost of remediation can be significant, revenues generated either cover or exceed the cost of delivering the remediation service. Additional research on remediation in pharmacy education across the United States and abroad is needed to make sound decisions in developing effective policies. This paper provides a review of current practices and recommendations for remediation in pharmacy and health care education.


Subject(s)
Education, Pharmacy/methods , Education, Professional , Remedial Teaching/methods , Accreditation , Cost-Benefit Analysis , Education, Pharmacy/standards , Education, Professional/standards , Educational Measurement , Guidelines as Topic , Humans , Learning , Organizational Policy , Program Evaluation , Remedial Teaching/economics , School Admission Criteria , Schools, Pharmacy/standards , Self Efficacy , Students, Pharmacy/psychology , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...